Heron Therapeutics (HRTX) Receivables - Other: 2020-2024
- Heron Therapeutics' Receivables - Other fell 15.16% to $263,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $263,000, marking a year-over-year decrease of 15.16%. This contributed to the annual value of $263,000 for FY2024, which is 15.16% down from last year.
- Latest data reveals that Heron Therapeutics reported Receivables - Other of $263,000 as of Q4 2024, which was down 15.16% from $310,000 recorded in Q4 2023.
- In the past 5 years, Heron Therapeutics' Receivables - Other registered a high of $6.2 million during Q4 2022, and its lowest value of $245,000 during Q4 2021.
- Its 3-year average for Receivables - Other is $2.3 million, with a median of $310,000 in 2023.
- As far as peak fluctuations go, Heron Therapeutics' Receivables - Other soared by 2,429.39% in 2022, and later tumbled by 95.00% in 2023.
- Over the past 5 years, Heron Therapeutics' Receivables - Other (Quarterly) stood at $334,000 in 2020, then decreased by 26.65% to $245,000 in 2021, then spiked by 2,429.39% to $6.2 million in 2022, then plummeted by 95.00% to $310,000 in 2023, then decreased by 15.16% to $263,000 in 2024.
- Its Receivables - Other stands at $263,000 for Q4 2024, versus $310,000 for Q4 2023 and $6.2 million for Q4 2022.
